 | • レポートコード：GIR-105X02548 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Medical Devices & Consumables |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、バイオ医薬品バッファーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。バイオ医薬品バッファーの種類別市場規模（滅菌バッファー、非滅菌バッファー）、用途別市場規模（組換えタンパク質、モノクローナル抗体、抗生物質、プロバイオティクス、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・バイオ医薬品バッファーの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GE Healthcare、Thermo Fisher Scientific、Danaher Corporation、Sartorius StedimBiotech、Merck、Eppendorf、Roche、Nova Biomedicals、Lonza、Becton, and Dickinson and Company、GEA ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：滅菌バッファー、非滅菌バッファー ・用途別分析2016年-2026年：組換えタンパク質、モノクローナル抗体、抗生物質、プロバイオティクス、その他 ・バイオ医薬品バッファーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・バイオ医薬品バッファーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・バイオ医薬品バッファーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・バイオ医薬品バッファーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・バイオ医薬品バッファーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Biopharmaceutical Buffers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Biopharmaceutical Buffers size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Biopharmaceutical Buffers market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Biopharmaceutical Buffers market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Sterile Buffer
Non-sterile Buffer
Market segment by Application can be divided into
Recombinant Proteins
Monoclonal Antibodies
Antibiotics
Probiotics
Other
The key market players for global Biopharmaceutical Buffers market are listed below:
GE Healthcare
Thermo Fisher Scientific
Danaher Corporation
Sartorius StedimBiotech
Merck
Eppendorf
Roche
Nova Biomedicals
Lonza
Becton, and Dickinson and Company
GEA
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Biopharmaceutical Buffers Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biopharmaceutical Buffers Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Sterile Buffer
1.2.3 Non-sterile Buffer
1.3 Market Analysis by Application
1.3.1 Overview: Global Biopharmaceutical Buffers Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Recombinant Proteins
1.3.3 Monoclonal Antibodies
1.3.4 Antibiotics
1.3.5 Probiotics
1.3.6 Other
1.4 Global Biopharmaceutical Buffers Market Size & Forecast
1.4.1 Global Biopharmaceutical Buffers Sales in Value (2016-2026))
1.4.2 Global Biopharmaceutical Buffers Sales in Volume (2016-2026)
1.4.3 Global Biopharmaceutical Buffers Price by Type (2016-2026) & (USD/MT)
1.5 Global Biopharmaceutical Buffers Production Capacity Analysis
1.5.1 Global Biopharmaceutical Buffers Total Production Capacity (2016-2026)
1.5.2 Global Biopharmaceutical Buffers Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Biopharmaceutical Buffers Market Drivers
1.6.2 Biopharmaceutical Buffers Market Restraints
1.6.3 Biopharmaceutical Buffers Trends Analysis
2 Manufacturers Profiles
2.1 GE Healthcare
2.1.1 GE Healthcare Details
2.1.2 GE Healthcare Major Business
2.1.3 GE Healthcare Biopharmaceutical Buffers Product and Services
2.1.4 GE Healthcare Biopharmaceutical Buffers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Biopharmaceutical Buffers Product and Services
2.2.4 Thermo Fisher Scientific Biopharmaceutical Buffers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Danaher Corporation
2.3.1 Danaher Corporation Details
2.3.2 Danaher Corporation Major Business
2.3.3 Danaher Corporation Biopharmaceutical Buffers Product and Services
2.3.4 Danaher Corporation Biopharmaceutical Buffers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Sartorius StedimBiotech
2.4.1 Sartorius StedimBiotech Details
2.4.2 Sartorius StedimBiotech Major Business
2.4.3 Sartorius StedimBiotech Biopharmaceutical Buffers Product and Services
2.4.4 Sartorius StedimBiotech Biopharmaceutical Buffers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Biopharmaceutical Buffers Product and Services
2.5.4 Merck Biopharmaceutical Buffers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Eppendorf
2.6.1 Eppendorf Details
2.6.2 Eppendorf Major Business
2.6.3 Eppendorf Biopharmaceutical Buffers Product and Services
2.6.4 Eppendorf Biopharmaceutical Buffers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Biopharmaceutical Buffers Product and Services
2.7.4 Roche Biopharmaceutical Buffers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Nova Biomedicals
2.8.1 Nova Biomedicals Details
2.8.2 Nova Biomedicals Major Business
2.8.3 Nova Biomedicals Biopharmaceutical Buffers Product and Services
2.8.4 Nova Biomedicals Biopharmaceutical Buffers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Lonza
2.9.1 Lonza Details
2.9.2 Lonza Major Business
2.9.3 Lonza Biopharmaceutical Buffers Product and Services
2.9.4 Lonza Biopharmaceutical Buffers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Becton, and Dickinson and Company
2.10.1 Becton, and Dickinson and Company Details
2.10.2 Becton, and Dickinson and Company Major Business
2.10.3 Becton, and Dickinson and Company Biopharmaceutical Buffers Product and Services
2.10.4 Becton, and Dickinson and Company Biopharmaceutical Buffers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 GEA
2.11.1 GEA Details
2.11.2 GEA Major Business
2.11.3 GEA Biopharmaceutical Buffers Product and Services
2.11.4 GEA Biopharmaceutical Buffers Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Biopharmaceutical Buffers Sales by Manufacturer
3.1 Global Biopharmaceutical Buffers Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Biopharmaceutical Buffers Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Biopharmaceutical Buffers
3.4 Market Concentration Rate
3.4.1 Top 3 Biopharmaceutical Buffers Manufacturer Market Share
3.4.2 Top 6 Biopharmaceutical Buffers Manufacturer Market Share
3.5 Global Biopharmaceutical Buffers Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Biopharmaceutical Buffers Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Biopharmaceutical Buffers Market Size by Region
4.1.1 Global Biopharmaceutical Buffers Sales in Volume by Region (2016-2026)
4.1.2 Global Biopharmaceutical Buffers Revenue by Region (2016-2026)
4.2 North America Biopharmaceutical Buffers Revenue (2016-2026)
4.3 Europe Biopharmaceutical Buffers Revenue (2016-2026)
4.4 Asia-Pacific Biopharmaceutical Buffers Revenue (2016-2026)
4.5 South America Biopharmaceutical Buffers Revenue (2016-2026)
4.6 Middle East and Africa Biopharmaceutical Buffers Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Biopharmaceutical Buffers Sales in Volume by Type (2016-2026)
5.2 Global Biopharmaceutical Buffers Revenue by Type (2016-2026)
5.3 Global Biopharmaceutical Buffers Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Biopharmaceutical Buffers Sales in Volume by Application (2016-2026)
6.2 Global Biopharmaceutical Buffers Revenue by Application (2016-2026)
6.3 Global Biopharmaceutical Buffers Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Biopharmaceutical Buffers Sales by Type (2016-2026)
7.2 North America Biopharmaceutical Buffers Sales by Application (2016-2026)
7.3 North America Biopharmaceutical Buffers Market Size by Country
7.3.1 North America Biopharmaceutical Buffers Sales in Volume by Country (2016-2026)
7.3.2 North America Biopharmaceutical Buffers Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Biopharmaceutical Buffers Sales by Type (2016-2026)
8.2 Europe Biopharmaceutical Buffers Sales by Application (2016-2026)
8.3 Europe Biopharmaceutical Buffers Market Size by Country
8.3.1 Europe Biopharmaceutical Buffers Sales in Volume by Country (2016-2026)
8.3.2 Europe Biopharmaceutical Buffers Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Biopharmaceutical Buffers Sales by Type (2016-2026)
9.2 Asia-Pacific Biopharmaceutical Buffers Sales by Application (2016-2026)
9.3 Asia-Pacific Biopharmaceutical Buffers Market Size by Region
9.3.1 Asia-Pacific Biopharmaceutical Buffers Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Biopharmaceutical Buffers Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Biopharmaceutical Buffers Sales by Type (2016-2026)
10.2 South America Biopharmaceutical Buffers Sales by Application (2016-2026)
10.3 South America Biopharmaceutical Buffers Market Size by Country
10.3.1 South America Biopharmaceutical Buffers Sales in Volume by Country (2016-2026)
10.3.2 South America Biopharmaceutical Buffers Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Biopharmaceutical Buffers Sales by Type (2016-2026)
11.2 Middle East & Africa Biopharmaceutical Buffers Sales by Application (2016-2026)
11.3 Middle East & Africa Biopharmaceutical Buffers Market Size by Country
11.3.1 Middle East & Africa Biopharmaceutical Buffers Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Biopharmaceutical Buffers Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Biopharmaceutical Buffers Typical Distributors
12.3 Biopharmaceutical Buffers Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Biopharmaceutical Buffers Revenue by Type, (USD Million), 2021-2026
Table 2. Global Biopharmaceutical Buffers Revenue by Application, (USD Million), 2021-2026
Table 3. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. GE Healthcare Major Business
Table 5. GE Healthcare Biopharmaceutical Buffers Product and Services
Table 6. GE Healthcare Biopharmaceutical Buffers Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 8. Thermo Fisher Scientific Major Business
Table 9. Thermo Fisher Scientific Biopharmaceutical Buffers Product and Services
Table 10. Thermo Fisher Scientific Biopharmaceutical Buffers Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Danaher Corporation Basic Information, Manufacturing Base and Competitors
Table 12. Danaher Corporation Major Business
Table 13. Danaher Corporation Biopharmaceutical Buffers Product and Services
Table 14. Danaher Corporation Biopharmaceutical Buffers Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sartorius StedimBiotech Basic Information, Manufacturing Base and Competitors
Table 16. Sartorius StedimBiotech Major Business
Table 17. Sartorius StedimBiotech Biopharmaceutical Buffers Product and Services
Table 18. Sartorius StedimBiotech Biopharmaceutical Buffers Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Major Business
Table 21. Merck Biopharmaceutical Buffers Product and Services
Table 22. Merck Biopharmaceutical Buffers Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Eppendorf Basic Information, Manufacturing Base and Competitors
Table 24. Eppendorf Major Business
Table 25. Eppendorf Biopharmaceutical Buffers Product and Services
Table 26. Eppendorf Biopharmaceutical Buffers Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Roche Basic Information, Manufacturing Base and Competitors
Table 28. Roche Major Business
Table 29. Roche Biopharmaceutical Buffers Product and Services
Table 30. Roche Biopharmaceutical Buffers Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Nova Biomedicals Basic Information, Manufacturing Base and Competitors
Table 32. Nova Biomedicals Major Business
Table 33. Nova Biomedicals Biopharmaceutical Buffers Product and Services
Table 34. Nova Biomedicals Biopharmaceutical Buffers Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Lonza Basic Information, Manufacturing Base and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Biopharmaceutical Buffers Product and Services
Table 38. Lonza Biopharmaceutical Buffers Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Becton, and Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 40. Becton, and Dickinson and Company Major Business
Table 41. Becton, and Dickinson and Company Biopharmaceutical Buffers Product and Services
Table 42. Becton, and Dickinson and Company Biopharmaceutical Buffers Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. GEA Basic Information, Manufacturing Base and Competitors
Table 44. GEA Major Business
Table 45. GEA Biopharmaceutical Buffers Product and Services
Table 46. GEA Biopharmaceutical Buffers Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Biopharmaceutical Buffers Sales by Manufacturer (2019-2021e) & (K MT)
Table 48. Global Biopharmaceutical Buffers Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Biopharmaceutical Buffers, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Biopharmaceutical Buffers Production Capacity by Company, (K MT): 2020 VS 2021
Table 51. Head Office and Biopharmaceutical Buffers Production Site of Key Manufacturer
Table 52. Global Biopharmaceutical Buffers Sales by Region (2016-2021e) & (K MT)
Table 53. Global Biopharmaceutical Buffers Sales by Region (2021-2026) & (K MT)
Table 54. Global Biopharmaceutical Buffers Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Biopharmaceutical Buffers Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Biopharmaceutical Buffers Sales by Type (2016-2021e) & (K MT)
Table 57. Global Biopharmaceutical Buffers Sales by Type (2021-2026) & (K MT)
Table 58. Global Biopharmaceutical Buffers Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Biopharmaceutical Buffers Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Biopharmaceutical Buffers Price by Type (2016-2021e) & (USD/MT)
Table 61. Global Biopharmaceutical Buffers Price by Type (2021-2026) & (USD/MT)
Table 62. Global Biopharmaceutical Buffers Sales by Application (2016-2021e) & (K MT)
Table 63. Global Biopharmaceutical Buffers Sales by Application (2021-2026) & (K MT)
Table 64. Global Biopharmaceutical Buffers Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Biopharmaceutical Buffers Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Biopharmaceutical Buffers Price by Application (2016-2021e) & (USD/MT)
Table 67. Global Biopharmaceutical Buffers Price by Application (2021-2026) & (USD/MT)
Table 68. North America Biopharmaceutical Buffers Sales by Country (2016-2021e) & (K MT)
Table 69. North America Biopharmaceutical Buffers Sales by Country (2021-2026) & (K MT)
Table 70. North America Biopharmaceutical Buffers Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Biopharmaceutical Buffers Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Biopharmaceutical Buffers Sales by Type (2016-2021e) & (K MT)
Table 73. North America Biopharmaceutical Buffers Sales by Type (2021-2026) & (K MT)
Table 74. North America Biopharmaceutical Buffers Sales by Application (2016-2021e) & (K MT)
Table 75. North America Biopharmaceutical Buffers Sales by Application (2021-2026) & (K MT)
Table 76. Europe Biopharmaceutical Buffers Sales by Country (2016-2021e) & (K MT)
Table 77. Europe Biopharmaceutical Buffers Sales by Country (2021-2026) & (K MT)
Table 78. Europe Biopharmaceutical Buffers Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Biopharmaceutical Buffers Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Biopharmaceutical Buffers Sales by Type (2016-2021e) & (K MT)
Table 81. Europe Biopharmaceutical Buffers Sales by Type (2021-2026) & (K MT)
Table 82. Europe Biopharmaceutical Buffers Sales by Application (2016-2021e) & (K MT)
Table 83. Europe Biopharmaceutical Buffers Sales by Application (2021-2026) & (K MT)
Table 84. Asia-Pacific Biopharmaceutical Buffers Sales by Region (2016-2021e) & (K MT)
Table 85. Asia-Pacific Biopharmaceutical Buffers Sales by Region (2021-2026) & (K MT)
Table 86. Asia-Pacific Biopharmaceutical Buffers Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Biopharmaceutical Buffers Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Biopharmaceutical Buffers Sales by Type (2016-2021e) & (K MT)
Table 89. Asia-Pacific Biopharmaceutical Buffers Sales by Type (2021-2026) & (K MT)
Table 90. Asia-Pacific Biopharmaceutical Buffers Sales by Application (2016-2021e) & (K MT)
Table 91. Asia-Pacific Biopharmaceutical Buffers Sales by Application (2021-2026) & (K MT)
Table 92. South America Biopharmaceutical Buffers Sales by Country (2016-2021e) & (K MT)
Table 93. South America Biopharmaceutical Buffers Sales by Country (2021-2026) & (K MT)
Table 94. South America Biopharmaceutical Buffers Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Biopharmaceutical Buffers Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Biopharmaceutical Buffers Sales by Type (2016-2021e) & (K MT)
Table 97. South America Biopharmaceutical Buffers Sales by Type (2021-2026) & (K MT)
Table 98. South America Biopharmaceutical Buffers Sales by Application (2016-2021e) & (K MT)
Table 99. South America Biopharmaceutical Buffers Sales by Application (2021-2026) & (K MT)
Table 100. Middle East & Africa Biopharmaceutical Buffers Sales by Country (2016-2021e) & (K MT)
Table 101. Middle East & Africa Biopharmaceutical Buffers Sales by Country (2021-2026) & (K MT)
Table 102. Middle East & Africa Biopharmaceutical Buffers Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Biopharmaceutical Buffers Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Biopharmaceutical Buffers Sales by Type (2016-2021e) & (K MT)
Table 105. Middle East & Africa Biopharmaceutical Buffers Sales by Type (2021-2026) & (K MT)
Table 106. Middle East & Africa Biopharmaceutical Buffers Sales by Application (2016-2021e) & (K MT)
Table 107. Middle East & Africa Biopharmaceutical Buffers Sales by Application (2021-2026) & (K MT)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Biopharmaceutical Buffers Typical Distributors
Table 111. Biopharmaceutical Buffers Typical Customers
List of Figures
Figure 1. Biopharmaceutical Buffers Picture
Figure 2. Global Biopharmaceutical Buffers Sales Market Share by Type in 2020
Figure 3. Sterile Buffer
Figure 4. Non-sterile Buffer
Figure 5. Global Biopharmaceutical Buffers Sales Market Share by Application in 2020
Figure 6. Recombinant Proteins
Figure 7. Monoclonal Antibodies
Figure 8. Antibiotics
Figure 9. Probiotics
Figure 10. Other
Figure 11. Global Biopharmaceutical Buffers Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 12. Global Biopharmaceutical Buffers Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Biopharmaceutical Buffers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Biopharmaceutical Buffers Sales (2016-2026) & (K MT)
Figure 33. Global Biopharmaceutical Buffers Production Capacity (2016-2026) & (K MT)
Figure 34. Global Biopharmaceutical Buffers Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Biopharmaceutical Buffers Market Drivers
Figure 36. Biopharmaceutical Buffers Market Restraints
Figure 37. Biopharmaceutical Buffers Market Trends
Figure 38. Global Biopharmaceutical Buffers Sales Market Share by Manufacturer in 2020
Figure 39. Global Biopharmaceutical Buffers Revenue Market Share by Manufacturer in 2020
Figure 40. Biopharmaceutical Buffers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Biopharmaceutical Buffers Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Biopharmaceutical Buffers Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Biopharmaceutical Buffers Sales Market Share by Region (2016-2026)
Figure 44. Global Biopharmaceutical Buffers Revenue Market Share by Region (2016-2026)
Figure 45. North America Biopharmaceutical Buffers Revenue (2016-2026) & (USD Million)
Figure 46. Europe Biopharmaceutical Buffers Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Biopharmaceutical Buffers Revenue (2016-2026) & (USD Million)
Figure 48. South America Biopharmaceutical Buffers Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Biopharmaceutical Buffers Revenue (2016-2026) & (USD Million)
Figure 50. Global Biopharmaceutical Buffers Sales Market Share by Type (2016-2026)
Figure 51. Global Biopharmaceutical Buffers Revenue Market Share by Type (2016-2026)
Figure 52. Global Biopharmaceutical Buffers Price by Type (2016-2026) & (USD/MT)
Figure 53. Global Biopharmaceutical Buffers Sales Market Share by Application (2016-2026)
Figure 54. Global Biopharmaceutical Buffers Revenue Market Share by Application (2016-2026)
Figure 55. Global Biopharmaceutical Buffers Price by Application (2016-2026) & (USD/MT)
Figure 56. North America Biopharmaceutical Buffers Sales Market Share by Country (2016-2026)
Figure 57. North America Biopharmaceutical Buffers Revenue Market Share by Country (2016-2026)
Figure 58. North America Biopharmaceutical Buffers Sales Market Share by Type (2016-2026)
Figure 59. North America Biopharmaceutical Buffers Sales Market Share by Application (2016-2026)
Figure 60. Europe Biopharmaceutical Buffers Sales Market Share by Country (2016-2026)
Figure 61. Europe Biopharmaceutical Buffers Revenue Market Share by Country (2016-2026)
Figure 62. Europe Biopharmaceutical Buffers Sales Market Share by Type (2016-2026)
Figure 63. Europe Biopharmaceutical Buffers Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Biopharmaceutical Buffers Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Biopharmaceutical Buffers Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Biopharmaceutical Buffers Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Biopharmaceutical Buffers Sales Market Share by Application (2016-2026)
Figure 68. South America Biopharmaceutical Buffers Sales Market Share by Country (2016-2026)
Figure 69. South America Biopharmaceutical Buffers Revenue Market Share by Country (2016-2026)
Figure 70. South America Biopharmaceutical Buffers Sales Market Share by Type (2016-2026)
Figure 71. South America Biopharmaceutical Buffers Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Biopharmaceutical Buffers Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Biopharmaceutical Buffers Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Biopharmaceutical Buffers Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Biopharmaceutical Buffers Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のバイオ医薬品発酵槽市場 2021：企業別、地域別、種類・用途別 The Biopharmaceutical Fermenters market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…- バイオ医薬品の世界市場予測 2023年：メーカー別、地域別、種類・用途別 A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood compon…
- 世界のバイオ医薬品培地市場 2021：企業別、地域別、種類・用途別 The Biopharmaceutical Culture Media market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- バイオ医薬品発酵システムの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Biopharmaceutical fermentation system refers to a biopharmaceutical equipment, it can be divided into fermenters, bioprocess analyzers, process monitoring devices, culture & media preparation. Scope of the Report: This report focuses on the Biopharmaceutical Fermentation Systems in global market, es…
- 世界のバッファ・ラインドライバー市場 2021：企業別、地域別、種類・用途別 The Buffers and Line Drivers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…